Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar;13(1):34-40.
doi: 10.1177/19253621231160417. Epub 2023 Mar 30.

Postmortem Mitragynine Distribution in a Single Drug Fatality Case

Postmortem Mitragynine Distribution in a Single Drug Fatality Case

Dani C Mata et al. Acad Forensic Pathol. 2023 Mar.

Abstract

A 32-year-old Caucasian male was found unconscious at his sober-living home and pronounced dead after transportation to the emergency room. The decedent had a documented history of substance-use disorder and past suicide attempts, but according to his family, he was sober for the past year. Significant autopsy findings were cardiomegaly, hepatomegaly, congested lungs, cerebral edema, and obesity. The toxicology examination of blood and tissues using liquid chromatography tandem mass spectrometry detected only mitragynine in the central blood (7.5 mg/L), peripheral blood (3.3 mg/L), liver (42.2 mg/kg), and gastric contents (33.1 mg). The qualitative identification of 7-hydroxymitragynine was performed only on the central blood. The pathologist ruled the cause of death acute mitragynine intoxication combined with cardiomegaly with left ventricular hypertrophy, with severe hepatomegaly and obesity listed as other significant conditions. The mode, or manner, of death was determined to be an accidental overdose. To the authors' knowledge, this is the first reported case where mitragynine was the only drug detected. This case study will contribute to the understanding of mitragynine-only death investigation and provide valuable toxicology information for medical examiners and pathologists.

Keywords: Forensic pathology; Kratom; Mitragynine; Overdose; Pathology; Postmortem toxicology.

PubMed Disclaimer

Conflict of interest statement

The authors, reviewers, editors, and publication staff do not report any relevant conflicts of interest.

References

    1. Corkery JM, Streete P, Claridge H, et al.Characteristics of deaths associated with kratom use. J Psychopharmacol. 2019;33(9):1102–1123. - PubMed
    1. Schimmel J, Amioka E, Rockhill K, et al.Prevalence and description of kratom (Mitragyna speciosa) use in the United States: a cross-sectional study. Addiction. 2021;116(1):176–181. - PubMed
    1. Eastlack SC, Cornett EM, Kaye AD. Kratom—Pharmacology, clinical implications, and outlook: a comprehensive review. Pain Ther. 2020;9(1):55–69. - PMC - PubMed
    1. Pantano F, Tittarelli R, Mannocchi G, et al.Hepatotoxicity induced by “the 3Ks”: kava, kratom, and khat. Int J Mol Sci. 2016;17(4):580. - PMC - PubMed
    1. Mata DC, Andera KM. Case series: Mitragynine blood and tissue concentrations in fatalities from 2017-2018 in Orange County, CA, USA. Forensic Chemistry; 2020.